Steven W Dow Selected Research

1- (2- (9- octadecenoyloxy)ethyl)- 2- (8- heptadecenyl)- 3- (hydroxyethyl)imidazolinium

4/2004

Growth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven W Dow Research Topics

Disease

16	Infections 12/2017 - 09/2005
12	Neoplasms (Cancer) 01/2022 - 09/2003
6	Inflammation (Inflammations) 07/2020 - 07/2009
4	Melioidosis 12/2013 - 05/2010
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 03/2006
3	Chronic Renal Insufficiency 04/2013 - 06/2011
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
2	Synovitis 07/2020 - 01/2018
2	Asthma (Bronchial Asthma) 12/2016 - 07/2009
2	Respiratory Hypersensitivity 12/2016 - 07/2009
2	Melanoma (Melanoma, Malignant) 10/2014 - 09/2003
1	Infectious Arthritis (Septic Arthritis) 04/2021
1	Wounds and Injuries (Trauma) 07/2020
1	Experimental Melanoma 10/2018
1	Human Influenza (Influenza) 02/2013
1	Fibrosis (Cirrhosis) 02/2013
1	Burkholderia Infections 01/2013
1	Persistent Infection 01/2013
1	Glanders 01/2013
1	Tularemia 07/2012
1	Viremia 03/2012
1	Critical Illness (Critically Ill) 09/2010
1	Sepsis (Septicemia) 09/2010
1	Metaplasia 07/2009
1	Eosinophilia 07/2009
1	Anorexia 01/2007
1	Diarrhea 01/2007
1	Hemangiosarcoma (Angiosarcoma) 01/2007
1	Rhinitis 12/2006
1	Sneezing 12/2006
1	Lymphoma (Lymphomas) 03/2006
1	Virus Diseases (Viral Diseases) 03/2006
1	Tuberculosis (Tuberculoses) 09/2005
1	Atopic Dermatitis (Atopic Eczema) 02/2005
1	Pruritus (Itching) 02/2005

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 12/2017 - 02/2005
7	VaccinesIBA 12/2013 - 02/2005
6	CytokinesIBA 02/2013 - 04/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 03/2010
4	DNA (Deoxyribonucleic Acid)IBA 03/2006 - 09/2003
3	Peptides (Polypeptides)IBA 12/2017 - 07/2006
3	AllergensIBA 12/2016 - 02/2005
3	EpitopesIBA 09/2006 - 09/2005
3	Liposomes (Liposome)IBA 03/2006 - 04/2004
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2019
2	Losartan (Cozaar)FDA LinkGeneric 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 07/2006
2	Complement System Proteins (Complement)IBA 01/2014 - 01/2012
2	Clodronic Acid (Clodronate)IBA 11/2012 - 11/2005
2	AerosolsIBA 01/2012 - 09/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2007 - 03/2006
1	Phosphotransferases (Kinase)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	CCR2 ReceptorsIBA 01/2019
1	Therapeutic UsesIBA 10/2018
1	AntibodiesIBA 10/2018
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2018
1	insect maxadilan proteinIBA 12/2017
1	aluminum sulfate (alum)IBA 12/2017
1	Methacholine Chloride (Methacholine)FDA Link 12/2016
1	AS 35IBA 02/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2014
1	Virulence Factors (Pathogenicity Factors)IBA 01/2014
1	Lipase (Acid Lipase)FDA Link 01/2014
1	Hemolysin Proteins (Hemolysins)IBA 01/2014
1	Vaccine AdjuvantsIBA 12/2012
1	InterferonsIBA 11/2012
1	Interleukin-17 (Interleukin 17)IBA 11/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2012
1	Gentamicins (Gentamicin)FDA LinkGeneric 07/2012
1	Immunoglobulin A (IgA)IBA 05/2012
1	Saline SolutionIBA 03/2012
1	Hemin (Panhematin)FDA Link 01/2012
1	Ferritins (Ferritin)IBA 01/2012
1	IronIBA 01/2012
1	Polysaccharides (Glycans)IBA 01/2012
1	SiderophoresIBA 01/2012
1	ChemokinesIBA 09/2010
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2010
1	Ceftazidime (Fortum)FDA LinkGeneric 05/2010
1	Cancer VaccinesIBA 01/2007
1	Monophenol Monooxygenase (Tyrosinase)IBA 07/2006
1	Pharmaceutical PreparationsIBA 03/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2005
1	PolyproteinsIBA 09/2005
1	alpha chain interleukin-7 receptorIBA 09/2005
1	Interleukin-4 (Interleukin 4)IBA 02/2005
1	Nucleic AcidsIBA 02/2005
1	LipidsIBA 04/2004
1	1- (2- (9- octadecenoyloxy)ethyl)- 2- (8- heptadecenyl)- 3- (hydroxyethyl)imidazoliniumIBA 04/2004

Therapy/Procedure

11	Therapeutics 01/2022 - 12/2006
8	Immunotherapy 01/2019 - 02/2005
2	Intravenous Infusions 12/2016 - 04/2013
2	Drug Therapy (Chemotherapy) 01/2007 - 03/2006
1	Intra-Articular Injections 07/2020
1	Debridement 07/2020
1	Catheters 02/2014
1	Intradermal Injections 02/2005